| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.655.793 | 4.019.902 | 3.839.788 | 3.543.122 | 3.572.335 | 3.826.477 | 4.382.116 | 4.960.249 | 5.401.424 | 5.115.149 |
| Total Income - EUR | 3.686.340 | 4.050.839 | 3.858.702 | 3.603.333 | 3.595.281 | 3.864.756 | 4.408.272 | 4.995.096 | 5.432.137 | 5.146.319 |
| Total Expenses - EUR | 3.606.945 | 3.960.392 | 3.728.779 | 3.519.207 | 3.456.636 | 3.653.767 | 4.220.850 | 4.916.930 | 5.332.110 | 5.026.917 |
| Gross Profit/Loss - EUR | 79.395 | 90.447 | 129.924 | 84.126 | 138.645 | 210.990 | 187.422 | 78.166 | 100.028 | 119.402 |
| Net Profit/Loss - EUR | 57.747 | 65.263 | 102.360 | 61.400 | 113.895 | 172.051 | 153.845 | 55.623 | 73.732 | 94.469 |
| Employees | 21 | 21 | 21 | 17 | 14 | 14 | 12 | 14 | 13 | 12 |
Check the financial reports for the company - Enzymes & Derivates Sa
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 36.364 | 33.980 | 44.469 | 83.940 | 101.230 | 134.936 | 127.331 | 125.951 | 99.361 | 71.366 |
| Current Assets | 1.230.281 | 1.365.515 | 1.481.190 | 1.186.837 | 1.246.747 | 1.280.821 | 1.418.556 | 1.503.536 | 1.617.864 | 1.394.126 |
| Inventories | 287.950 | 260.599 | 283.559 | 218.440 | 288.225 | 234.480 | 252.457 | 262.029 | 291.120 | 306.550 |
| Receivables | 966.385 | 1.164.921 | 1.256.888 | 1.028.900 | 997.695 | 1.036.032 | 1.159.001 | 1.193.708 | 1.454.306 | 1.158.691 |
| Cash | -24.054 | -60.005 | -59.256 | -60.503 | -39.173 | 10.310 | 7.098 | 47.800 | -127.562 | -71.115 |
| Shareholders Funds | 704.345 | 757.782 | 795.204 | 615.427 | 694.810 | 802.667 | 780.373 | 833.629 | 902.702 | 824.426 |
| Social Capital | 33.402 | 32.836 | 64.468 | 30.345 | 29.770 | 29.110 | 29.200 | 29.111 | 28.949 | 28.563 |
| Debts | 562.300 | 641.713 | 730.455 | 655.350 | 653.166 | 613.090 | 765.514 | 795.858 | 814.523 | 641.065 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 5.0415 | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Enzymes & Derivates Sa